检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:薛安[1] 周跃君 XUE An;ZHOU Yuejun(Department of Obstetrics and Gynecology,the People's Hospital of Boluo County,Huizhou 516100,China)
出 处:《临床医学工程》2021年第11期1477-1478,共2页Clinical Medicine & Engineering
摘 要:目的探讨宫颈球囊扩张联合静脉滴注小剂量催产素催产的临床效果。方法选取2019年6月至2020年5月我院收治的70例阴道试产且宫颈不成熟的足月初产妇,随机分为观察组和对照组各35例。观察组给予宫颈球囊扩张联合静脉滴注小剂量催产素催产,对照组采用静脉滴注小剂量催产素催产。比较两组的试产成功率、产程时长及母婴结局。结果观察组的试产成功率为94.29%,明显高于对照组的77.14%,差异有统计学意义(P<0.05)。观察组的第一产程潜伏期、活跃期时长,第二产程时长及总产程时长均明显短于对照组,差异有统计学意义(P<0.05)。观察组的不良母婴结局发生率为22.86%,明显低于对照组的45.71%,差异有统计学意义(P<0.05)。结论宫颈球囊扩张联合静脉滴注小剂量催产素催产能够有效促进宫颈成熟,提高试产成功率,降低不良母婴结局发生率,具有较高的临床应用价值。Objective To explore the clinical effect of cervical balloon dilatation combined with intravenous drip of low-dose oxytocin for expediting child delivery.Methods 70 full-term primiparas with immature cervix and vaginal trial delivery in our hospital from June 2019 to May 2020 were selected and randomly divided into observation group and control group,with 35 cases in each group.The observation group was given cervical balloon dilatation combined with intravenous drip of low-dose oxytocin,while the control group was given intravenous drip of low-dose oxytocin.The success rate of trial delivery,labor duration,and maternal and infant outcomes were compared between the two groups.Results The success rate of trial delivery in the observation group was 94.29%,significantly higher than 77.14%in the control group(P<0.05).The latency and active period of first stage of labor,second stage of labor,and total duration of labor in the observation group were significantly shorter than those in the control group(P<0.05).The incidence of adverse maternal and infant outcomes in the observation group was 22.86%,significantly lower than 45.71%in the control group(P<0.05).Conclusions Cervical balloon dilatation combined with low-dose oxytocin can effectively promote the cervical ripening,improve the success rate of trial delivery,and reduce the incidence of adverse maternal and infant outcomes,with higher clinical application value.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.49